Search
Amarin Corporation PLC
AMRNAdd to Watchlist
16.370USD
-0.100-0.61%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
340.67MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.61%
5 Days
+2.89%
1 Month
+18.62%
6 Months
+19.31%
Year to Date
+17.31%
1 Year
-2.15%
Key Figures
16.640Open
16.790High
91.70KVolume
LossP/E TTM
12.15P/E Dynamic
--Dividend TTM
0.44%Turnover Ratio
16.470Prev. Close
16.180Low
1.06MTurnover
LossP/E Static
0.74P/B
0.00%Div Yield TTM
-5.17%ROA
20.90052wk High
1.81Volume Ratio
-82.18MNet Profit
20.81MShares
-1.6122EPS TTM
0.82Beta
-7.28%ROE
11.27052wk Low
3.70%Amplitude
36.84%Gross Margin
340.67MMarket Cap
7.07Reward/Risk
2.74%Risk Rate
TradingKey Stock Score of Amarin Corporation PLC
Currency: USD Updated: 2026-07-02Key Insights
Amarin Corporation PLC's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 113 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Amarin Corporation PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Amarin Corporation PLC Highlights
StrengthsRisks
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Fairly Valued
The company’s latest PE is -10.15, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.71M shares, decreasing 7.88% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 239.67K shares of this stock.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
12.000
Target Price
-27.14%
Upside Space
Amarin Corporation PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Amarin Corporation PLC Info
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Ticker SymbolAMRN
CompanyAmarin Corporation PLC
CEOBerg (Aaron D)
Websitehttps://amarincorp.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Amarin Corporation PLC (AMRN)?
The current price of Amarin Corporation PLC (AMRN) is 16.37.
What is the symbol of Amarin Corporation PLC?
The ticker symbol of Amarin Corporation PLC is AMRN.
What is the 52-week high of Amarin Corporation PLC?
The 52-week high of Amarin Corporation PLC is 20.90.
What is the 52-week low of Amarin Corporation PLC?
The 52-week low of Amarin Corporation PLC is 11.27.
What is the market capitalization of Amarin Corporation PLC?
The market capitalization of Amarin Corporation PLC is 340.67M.
Is Amarin Corporation PLC (AMRN) currently rated as Buy, Hold, or Sell?
According to analysts, Amarin Corporation PLC (AMRN) has an overall rating of signal_hold, with a price target of 12.00.
What is the Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN)?
The Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN) is -37.40.